Immunoglobulin free light chain-kappa, a novel biomarker of inflammation and cardiovascular risk, decreases after smoking cessation in association with NT-proBNP

Back

ESC Professional Premium Access

Immunoglobulin free light chain-kappa, a novel biomarker of inflammation and cardiovascular risk, decreases after smoking cessation in association with NT-proBNP

Session: Smoking, mental health, and heart disease

Topic: Tobacco

Speaker: Professor K. Hasegawa (Kyoto, JP)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Koji Hasegawa

National Hospital Organization Kyoto Medical Center, Kyoto (Japan)

2 presentations

1 follower

6 more presentations in this session

The identification, referral and management of patients with cardiac-related distress: a new model to support psychological recovery after a cardiac event

Speaker: Professor A. Jackson (Melbourne, AU)

Smoking cessation medicines and e-cigarettes in smokers with obesity

Speaker: Doctor D. Terentes-Printzios (Athens, GR)

Fear of recurrence and its association with mental health outcomes after spontaneous coronary artery dissection (SCAD)

Speaker: Ms S. Clarke (Melbourne, AU)

Score-2 in heavy smokers: are we underestimating the risk?

Speaker: Doctor D. Cosmi (Perugia, IT)

The Cardiovascular Disease Burden Associated with secondhand smoke, 1990-2019: an age-period-cohort analysis of the Global Burden of Disease study

Speaker: Doctor H. Jiang (Beijing, CN)

Access the full session

Smoking, mental health, and heart disease

Speakers: Professor K. Hasegawa, Professor A. Jackson, Doctor D. Terentes-Printzios, Ms S. Clarke, Doctor D. Cosmi...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources